Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
- EV-302 Trial Investigators
- Queen Mary University of London
- Hospital Universitario Virgen del Rocio
- Cleveland Clinic Foundation
- Klinikum Stuttgart
- St. Marianna University School of Medicine
- Johns Hopkins University
- Memorial Sloan-Kettering Cancer Center
- AZ Maria Middelares
- University of Antwerp
- Yonsei University
- Hospital Universitario 12 de Octubre
- University Eye Clinic
- Veterans General Hospital-Taichung Taiwan
- Ministry of Health, Turkey
- University of California at Irvine
- Gustave Roussy
- Centre Léon Bérard
- Hospital Universitario Marques de Valdecilla
- University of California at Los Angeles
- Seagen Inc.
- Astellas Pharma Inc.
- Merck
- Netherlands Cancer Institute
Research output: Contribution to journal › Article › peer-review
845
Link opens in a new tab
Scopus
citations